• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过药理激活的 p53 抑制糖酵解酶:针对瓦博格效应治疗癌症。

Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Nobelsväg 16, Stockholm, SE 171 77, Sweden; Department of Biotechnology, Division of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Kladki 24, 80-822 Gdansk, Poland.

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Nobelsväg 16, Stockholm, SE 171 77, Sweden.

出版信息

J Biol Chem. 2011 Dec 2;286(48):41600-41615. doi: 10.1074/jbc.M111.240812. Epub 2011 Aug 23.

DOI:10.1074/jbc.M111.240812
PMID:21862591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3308870/
Abstract

Unique sensitivity of tumor cells to the inhibition of glycolysis is a good target for anticancer therapy. Here, we demonstrate that the pharmacologically activated tumor suppressor p53 mediates the inhibition of glycolytic enzymes in cancer cells in vitro and in vivo. We showed that p53 binds to the promoters of metabolic genes and represses their expression, including glucose transporters SLC2A12 (GLUT12) and SLC2A1 (GLUT1). Furthermore, p53-mediated repression of transcription factors c-Myc and HIF1α, key drivers of ATP-generating pathways in tumors, contributed to ATP production block. Inhibition of c-Myc by p53 mediated the ablation of several glycolytic genes in normoxia, whereas in hypoxia down-regulation of HIF1α contributed to this effect. We identified Sp1 as a transcription cofactor cooperating with p53 in the ablation of metabolic genes. Using different approaches, we demonstrated that glycolysis block contributes to the robust induction of apoptosis by p53 in cancer cells. Taken together, our data suggest that tumor-specific reinstatement of p53 function targets the "Achilles heel" of cancer cells (i.e. their dependence on glycolysis), which could contribute to the tumor-selective killing of cancer cells by pharmacologically activated p53.

摘要

肿瘤细胞对糖酵解抑制的独特敏感性是抗癌治疗的一个很好的靶点。在这里,我们证明了药理激活的肿瘤抑制因子 p53 在体外和体内介导了癌细胞中糖酵解酶的抑制。我们表明,p53 结合代谢基因的启动子并抑制其表达,包括葡萄糖转运蛋白 SLC2A12(GLUT12)和 SLC2A1(GLUT1)。此外,p53 介导的转录因子 c-Myc 和 HIF1α 的抑制,这些是肿瘤中产生 ATP 的途径的关键驱动因素,有助于 ATP 产生受阻。p53 通过抑制 c-Myc 介导了在常氧条件下几种糖酵解基因的消融,而在缺氧条件下 HIF1α 的下调有助于这种效应。我们确定 Sp1 是与 p53 合作在代谢基因消融中起转录共因子作用的蛋白。我们使用不同的方法证明了糖酵解阻断有助于 p53 在癌细胞中强烈诱导细胞凋亡。总之,我们的数据表明,肿瘤特异性恢复 p53 功能针对了癌细胞的“阿喀琉斯之踵”(即它们对糖酵解的依赖),这可能有助于通过药理激活的 p53 选择性杀死癌细胞。

相似文献

1
Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.通过药理激活的 p53 抑制糖酵解酶:针对瓦博格效应治疗癌症。
J Biol Chem. 2011 Dec 2;286(48):41600-41615. doi: 10.1074/jbc.M111.240812. Epub 2011 Aug 23.
2
Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.类固醇受体共激活因子-3 通过共激活缺氧诱导因子 1α 调节膀胱癌细胞中的葡萄糖代谢。
J Biol Chem. 2014 Apr 18;289(16):11219-11229. doi: 10.1074/jbc.M113.535989. Epub 2014 Feb 28.
3
Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.肿瘤抑制因子NDRG2通过抑制c-Myc表达来抑制结肠癌细胞中的糖酵解和谷氨酰胺分解代谢。
Oncotarget. 2015 Sep 22;6(28):26161-76. doi: 10.18632/oncotarget.4544.
4
TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.TNFα 和 IL-17 协同刺激人结直肠癌细胞的葡萄糖代谢和生长因子产生。
Mol Cancer. 2013 Jul 17;12:78. doi: 10.1186/1476-4598-12-78.
5
Hypoxic suppression of the cell cycle gene CDC25A in tumor cells.缺氧对肿瘤细胞中细胞周期基因CDC25A的抑制作用。
Cell Cycle. 2007 Aug 1;6(15):1919-26. doi: 10.4161/cc.6.15.4515. Epub 2007 May 27.
6
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD.肿瘤抑制因子p53通过其靶标RRAD对缺氧刺激的糖酵解起负调控作用。
Oncotarget. 2014 Jul 30;5(14):5535-46. doi: 10.18632/oncotarget.2137.
7
Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.通过稳定 p53,黄苓素靶向瓦博格效应表现出选择性抗肿瘤活性。
Pharmacol Res. 2018 Sep;135:49-59. doi: 10.1016/j.phrs.2018.07.011. Epub 2018 Jul 18.
8
Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.通过Myc抑制TXNIP实现三阴性乳腺癌中的代谢重编程
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5425-30. doi: 10.1073/pnas.1501555112. Epub 2015 Apr 13.
9
p53 represses c-Myc through induction of the tumor suppressor miR-145.p53通过诱导肿瘤抑制因子miR-145来抑制c-Myc。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12. doi: 10.1073/pnas.0808042106. Epub 2009 Feb 6.
10
LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect.长链非编码 RNA IDH1-AS1 通过 IDH1 连接 c-Myc 和 HIF1α 的功能来调节瓦博格效应。
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1465-E1474. doi: 10.1073/pnas.1711257115. Epub 2018 Jan 29.

引用本文的文献

1
Mechanisms of copper metabolism and cuproptosis: implications for liver diseases.铜代谢与铜死亡的机制:对肝脏疾病的影响
Front Immunol. 2025 Jul 30;16:1633711. doi: 10.3389/fimmu.2025.1633711. eCollection 2025.
2
PRMT1 promotes Warburg effect by regulating the PKM2/PKM1 ratio in non-small cell lung cancer.PRMT1 通过调节非小细胞肺癌中的 PKM2/PKM1 比值促进瓦博格效应。
Cell Death Dis. 2024 Jul 15;15(7):504. doi: 10.1038/s41419-024-06898-x.
3
Alteration of glucose metabolism and expression of glucose transporters in ovarian cancer.卵巢癌中葡萄糖代谢及葡萄糖转运蛋白表达的改变
Explor Target Antitumor Ther. 2024;5(2):384-399. doi: 10.37349/etat.2024.00224. Epub 2024 Apr 24.
4
The glucose transporter GLUT12, a new actor in obesity and cancer.葡萄糖转运蛋白GLUT12,肥胖和癌症领域的新成员。
J Physiol Biochem. 2024 May 10. doi: 10.1007/s13105-024-01028-9.
5
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.糖酵解途径中的转录调控和翻译后修饰在靶向癌症治疗中的作用。
Acta Pharmacol Sin. 2024 Aug;45(8):1533-1555. doi: 10.1038/s41401-024-01264-1. Epub 2024 Apr 15.
6
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.E2F-RB-p53通路在肿瘤抑制中的作用扩展
Biology (Basel). 2023 Dec 11;12(12):1511. doi: 10.3390/biology12121511.
7
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme Phenotype.显著的全身胰岛素抵抗与独特的多形性胶质母细胞瘤表型相关。
Clin Pathol. 2023 Oct 31;16:2632010X231207725. doi: 10.1177/2632010X231207725. eCollection 2023 Jan-Dec.
8
Cuproptosis in lung cancer: mechanisms and therapeutic potential.肺癌中的铜死亡:机制与治疗潜能。
Mol Cell Biochem. 2024 Jun;479(6):1487-1499. doi: 10.1007/s11010-023-04815-y. Epub 2023 Jul 22.
9
Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells.长链非编码RNA CCHE1调节乳酸脱氢酶A介导的糖酵解并赋予黑色素瘤细胞化学抗性。
Cancer Metab. 2023 Jul 21;11(1):10. doi: 10.1186/s40170-023-00309-z.
10
Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants.APR-246 和 COTI-2 对人源肿瘤原代培养 3-D 外植体的治疗靶点比较分析
Genes (Basel). 2023 Mar 19;14(3):747. doi: 10.3390/genes14030747.

本文引用的文献

1
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1.新型 p53 依赖性 S 期检查点的药理学激活涉及 CHK-1。
Cell Death Dis. 2011 May 19;2(5):e160. doi: 10.1038/cddis.2011.42.
2
Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX.通过 RITA 激活的 p53 消除 Wip1 的表达,通过激活 ATM 和抑制 HdmX 增强细胞凋亡诱导。
Cell Death Differ. 2011 Nov;18(11):1736-45. doi: 10.1038/cdd.2011.45. Epub 2011 May 6.
3
Advanced computational biology methods identify molecular switches for malignancy in an EGF mouse model of liver cancer.先进的计算生物学方法在 EGF 诱导的肝癌小鼠模型中鉴定出恶性肿瘤的分子开关。
PLoS One. 2011 Mar 28;6(3):e17738. doi: 10.1371/journal.pone.0017738.
4
Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors.Cdc25B 通过 Sp1 和 NF-Y 转录因子受到 p53 的负调控。
Oncogene. 2011 May 12;30(19):2282-8. doi: 10.1038/onc.2010.588. Epub 2011 Jan 17.
5
Emerging metabolic targets in cancer therapy.癌症治疗中的新兴代谢靶点。
Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1844-60. doi: 10.2741/3826.
6
Weak p53 permits senescence during cell cycle arrest.弱 p53 允许细胞周期停滞时衰老。
Cell Cycle. 2010 Nov 1;9(21):4323-7. doi: 10.4161/cc.9.21.13584. Epub 2010 Nov 10.
7
Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors.组蛋白去甲基化酶 LSD1 通过调节成肌因子诱导骨骼肌分化。
Biochem Biophys Res Commun. 2010 Oct 22;401(3):327-32. doi: 10.1016/j.bbrc.2010.09.014. Epub 2010 Sep 15.
8
Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer.p53/Sp1 调控失调导致肺癌中 DNA 甲基转移酶-1 的过表达。
Cancer Res. 2010 Jul 15;70(14):5807-17. doi: 10.1158/0008-5472.CAN-09-4161. Epub 2010 Jun 22.
9
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo.全基因组范围内分析 ETS 家族在体外和体内的 DNA 结合情况。
EMBO J. 2010 Jul 7;29(13):2147-60. doi: 10.1038/emboj.2010.106. Epub 2010 Jun 1.
10
Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents.DNA 损伤诱导剂抑制低氧诱导因子-1α(HIF-1α)蛋白合成。
PLoS One. 2010 May 7;5(5):e10522. doi: 10.1371/journal.pone.0010522.